TGFB1 and neoplasm: The three lesions larger than 10 mm that were missed by 89Zr-fresolimumab-PET were suspected to represent radionecrosis instead of viable tumor tissue (therefore probably lacking TGF-β expression), based on previous irradiation or disappearance on follow-up MRI.